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Abstract
Objective: The incidence of tuberculosis worldwide has emphasized the need for better assays designed to diagnose the disease, principally 
the extrapulmonary form. The objective of the present study was to validate the performance of an automated method for the determina-
tion of adenosine deaminase (ADA) activity in pleural fluid (PF) and cerebrospinal fluid (CSF), comparing it with a conventional method (the 
modified Giusti method). Methods: In total, 134 samples were selected from among those tested in our laboratory: 94 PF samples and 40 CSF 
samples. The ADA activity was determined using the two methods. Inter- and intra-assay precision was determined, linear regression analysis 
was performed, simple concordance tests were conducted, and the means of the differences were calculated. Results: The correlation coeffi-
cients for PF and CSF samples were, respectively, 0.96 and 0.95. Inter-assay precision was determined using 21 replicates at 3 different activity 
levels: low, medium and high. The percentage coefficient of variation (%CV) was, respectively, 5.9, 8.1 and 5.8 for PF samples, compared with 
21.9, 18.6 and 13.8 for CSF samples. Intra-assay precision in %CV was 1.3 and 11.7, respectively, for PF and CSF samples. The concordance 
between the methods in PF and CRF samples was, respectively, 96.8% and 100%, considering the reference values for the diagnosis of TB to be 
40 U/L (conventional) and 30 U/L (automated) in PF samples, versus 9 U/L (for both methods) in CSF samples. Conclusions: The results validate 
the use of the automated method of determining ADA activity in PF and CSF samples as an alternative to the conventional method.
Keywords: Adenosine deaminase; Tuberculosis/diagnosis; Pleural effusion; Cerebrospinal fluid.
Resumo
Objetivo: A incidência global de tuberculose reforça a necessidade de melhores ensaios para o diagnóstico desta doença, principalmente da 
tuberculose extrapulmonar. O objetivo do trabalho foi validar o desempenho de um método automatizado para a determinação da atividade 
de adenosina desaminase (ADA) no líquido pleural (LP) e no líquido cefalorraquidiano (LCR), comparando-o com um método convencional 
(Giusti modificado). Métodos: Selecionaram-se 134 amostras da rotina laboratorial: 94 de LP e 40 de LCR. Foram realizadas as determi-
nações da atividade de ADA através dos dois métodos. Calculou-se a precisão inter- e intra-ensaios, análise de regressão linear, testes de 
concordância simples e médias das diferenças. Resultados: Os coeficientes de correlação para as amostras de LP e LCR foram, respectiva-
mente, 0,96 e 0,95. A precisão interensaio foi determinada pela média de 21 amostras replicadas em ensaios diferentes para 3 níveis de 
atividade: baixa, média e alta. Os coeficientes de variação em porcentagem (%CV) foram, respectivamente, 5,9, 8,1 e 5,8 para amostras de LP; 
e 21,9, 18,6 e 13,8 para amostras de LCR, respectivamente. A precisão intra-ensaio em %CV foi, respectivamente, 1,3 e 11,7% para amostras 
de LP e LCR. A concordância entre os dois métodos em amostras de LP e LCR foi, respectivamente, 96,8% e 100%, considerando-se como 
valores de referência para o diagnóstico de TB 40 U/L (convencional) e 30 U/L (automatizado) em amostras de LP, e 9 U/L em amostras de 
LCR para os dois métodos. Conclusões: Os resultados validaram o método automatizado de determinação da atividade de ADA para o uso 
em amostras de LP e LCR como alternativa ao método convencional. 
Descritores: Adenosina desaminase; Tuberculose/diagnóstico; Derrame pleural; Líquido cefalorraquidiano.
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nonspecific granulomatous lesions without necrosis, 
especially in cases in which the microbiological 
study was not sufficient to establish the etiological 
diagnosis.(5,6)
Currently, serologic testing for antibodies using 
enzyme immunoassays or radioimmunoassays is 
not as definitive as is the isolation of the etiologic 
agent itself, since these assays usually have low 
specificity.(5,7)
The intradermal test, which is based on a delayed 
hypersensitivity reaction to purified protein deriva-
tive, can be used only as a screening test, since a 
positive result indicates only exposure to the bacillus 
or to the vaccine strain. In Brazil, mass vaccina-
tion with the bacillus Calmette-Guérin vaccine is a 
limiting factor for the use of this test.(8) It should be 
noted that immunocompromised patients present 
negative reactions even in the presence of a positive 
culture or active infection.(2,9)
The tuberculostearic acid present in 
Mycobacterium tuberculosis can be detected 
by gas chromatography and mass spectrometry. 
Despite being more sensitive, these techniques are 
less specific, as well as being more complex and 
more costly.(1)
If, in the diagnosis of pulmonary TB, we still 
have difficulty in finding methods that can meet the 
needs of clinical practice, in the case of extrapulmo-
nary TB, the situation is even worse. Conventional 
methods, which are useful for the diagnosis of 
pulmonary TB, perform poorly when PF or any 
other cavitary fluid is used in cases of extrapulmo-
nary TB.(1,7)
The recognition of these difficulties in the 
diagnosis of TB have led to the search for other 
methods that could optimize the approach to 
patients with pleural effusion who are suspected 
of having one or more of the several extrapulmo-
nary forms of this disease, such as meningeal, renal, 
pleural, osseous and lymph node TB. Chief among 
the new techniques are polymerase chain reaction, 
Introduction
The incidence of tuberculosis (TB) has 
increased worldwide; it is estimated that there are 
100,000 new cases annually, and 80% of those 
cases are concentrated in 22 countries, one of 
which is Brazil.(1,2) In Western countries, there has 
been an increase in the number of cases of pulmo-
nary and extrapulmonary TB, especially due to the 
prevalence of HIV infection.(3)
Clinical laboratories perform a series of tests 
that contribute to the diagnosis of TB. Direct testing 
for mycobacteria using Ziehl-Neelsen staining 
is considered a priority. Ziehl-Neelsen staining 
is extremely important, since treatment can be 
initiated immediately if the result is positive. In 
addition, it is an inexpensive test that is rapid and 
easily performed. Culture on Löwenstein-Jensen, or 
similar, medium is performed in parallel. However, 
sputum smear microscopy has a major problem, 
that of its low sensitivity.(2,4) Culture, although more 
sensitive, is limited by the time required to obtain 
results, which has an extremely negative effect on 
treatment.(3) In the case of pleural fluid (PF), the 
yield obtained by sputum smear microscopy is near 
zero, whereas the yield obtained by culture ranges 
from 10% to 35%. (5)
These factors make diagnosis even more diffi-
cult, Automated or semi-automated methods of 
mycobacterial growth in liquid media allow earlier 
diagnosis, since detection occurs between one and 
three weeks, compared with the three to eight 
weeks required when using solid media. Among 
such methods is the rapid radiometric system for 
detection of mycobacteria in clinical specimens 
(BACTEC 460 TB R; Becton Dickinson, Sparks, MD, 
USA), which is well established (international vali-
dation) and has been approved by the World Health 
Organization.(6) However, studies indicate that, 
in addition the problem created by the discharge 
of radioactive material, the rate of false-positive 
culture results, due to contamination between 
specimens during the machine reading, ranges 
from 1.4% to 4%.(6)
In Brazil, this system is falling into disuse in 
referral laboratories, being replaced by faster, 
nonradiometric systems, after assessment of their 
cost-effectiveness in different situations.(7)
Biopsy facilitates the differential diagnosis 
between granuloma with caseous necrosis and other 
Table 1 - Intra-assay precision determined by the mean, 
standard deviation and coefficient of variation of the 
repeated determinations.
Sample type Mean, U/L SD, U/L CV, %
Pleural fluid 16.3 0.2 1.3
Cerebrospinal fluid 0.6 0.07 11.7
CV: coefficient of variation; CV = 1.3 ± 0.2% for pleural fluid; 
and CV = 11.6 ± 0.07% for cerebrospinal fluid.
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used as a parameter that can meet all the criteria of 
a good diagnostic test.(18)
The objective of the present study was to test an 
automated method (commercial kit) for the determi-
nation of serum ADA activity in PF and cerebrospinal 
fluid (CSF) samples, as well as to standardize it for the 
first time, comparing its results with those obtained 
using the modified Giusti method, which is consid-
ered a reference test for our biochemical study.(16)
Methods
A total of 134 samples (94 PF samples and 
40 CSF samples) were selected from among 
those tested in the Central Laboratory of the 
Hospital São Paulo/Universidade Federal de São 
Paulo (HSP/UNIFESP, São Paulo Hospital/Federal 
University of São Paulo) and in the Laboratory 
of the Association for the Incentive Funding of 
Psychopharmacology/Laboratory Medicine. In the 
samples selected, ADA activity levels were previ-
ously determined, in-house, using a conventional 
method—the modified Giusti method.
which identifies M. tuberculosis DNA through the 
amplification of known genome sequences, and the 
techniques that detect biochemical markers, such as 
interferon gamma and adenosine deaminase (ADA), 
produced during the inflammatory process triggered 
by M. tuberculosis.(4,10)
This abbreviation—ADA—is a designation given 
to a group of enzymes with different molecular 
weights that have similar chemical functions in the 
metabolism of purines, catalyzing the conversion 
of adenosine and deoxyadenosine to inosine and 
deoxyinosine, respectively.(9) In nearly all verte-
brates, ADA is present. In humans, ADA is mainly 
found in T lymphocytes and is directly related 
to the activation of these cells. Activation of T 
lymphocytes can occur in various clinical situa-
tions in which increased ADA levels are found. The 
determination of ADA levels is particularly useful in 
cases of meningitis and tuberculous  pleuritis . (3,10-12) 
Therefore, the determination of ADA levels is 
extremely relevant for the laboratory testing-based 
diagnosis.(12)
Some researchers have reported that serum 
ADA activity is increased in patients with acute 
hepatitis or liver cirrhosis, as well as in those with 
other conditions.(10) Other authors have carried out 
studies relating ADA activity levels to diseases such 
as rheumatoid arthritis, lymphoproliferative disor-
ders, systemic lupus erythematosus, psoriasis and 
eclampsia.(13-15) However, due to its lack of specifi-
city, the determination of serum ADA activity has 
been more often used for the follow-up treatment 
of TB than for diagnosis. In the literature, there are 
innumerable studies involving the determination of 
ADA levels in cases of suspected TB, especially the 
extrapulmonary form, studies in which this group 
of enzymes is considered an excellent biochemical 
marker of TB.(7,9,10)
The determination of ADA levels has been 
performed using the method proposed by Giusti in 
1974,(16,17) and which has undergone certain modi-
fications over time. The modified Giusti method 
includes the Berthelot reaction in order to obtain 
better results.3,10,16) Despite being considered effi-
cient, this method still has a series of limitations: it 
requires reagent preparation; it is performed manu-
ally; readings are taken using a spectrophotometer; 
and all steps are performed in-house, that is, by each 
laboratory individually—therefore, there is a lack of 
standardization that does not allow this assay to be 
Table 2 - Inter-assay precision at three different activity 
levels (low, medium and high) using pleural fluid and 
cerebrospinal fluid samples.
Level Mean, U/L SD, U/L CV, %
Lowa 5.9 0.4 5.9
Mediuma 19.4 1.6 8.1
Higha 60.1 3.5 5.8
Lowb 0.8 0.2 21.9
Mediumb 5.4 1.0 18.6
Highb 7.2 1.0 13.8
CV: coefficient of variation; aPleural fluid samples; and bcer-
ebrospinal fluid samples.
Figure 1 - Correlation (linear regression) between the 
conventional (in-house) and the automated (Diazyme) 
methods for pleural fluid (PF) samples. The correlation 
coefficient (r) was 0.96.
y = 0.7648x + 0.6195
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used. The results obtained using the two methods 
are expressed in U/L.
Inter- and intra-assay precision tests were 
performed for the automated method. Intra-assay 
precision was determined using 21 replicates of PF 
and CSF. Inter-assay precision was determined using 
21 replicates at 3 different ADA activity levels in a 
pool of PF and CSF. Mean, standard deviation and 
coefficient of variation (CV) were calculated for the 
two types of precision (Tables 1 and 2).
The results obtained using the conventional 
method and those obtained using the automated 
method were submitted to the correlation test 
(Figures 1 and 2) and the simple concordance test 
in order to determine the equivalence between 
them,(17-19) considering the reference values for 
the diagnosis of TB in PF samples to be 40 U/L 
(modified Giusti method) and 30 U/L (automated 
method), versus 9 U/L (for both methods) in CSF 
samples (Table 3).
During the study, the stability of the automated 
method reagents was evaluated for one year. The 
sample volume needed when assays are performed 
using the automated method was also evaluated, 
as were execution time and the time needed for 
obtaining results.
Results
Intra-assay precision for each type of biological 
fluid, which was determined using 21 assay repli-
cates of PF and CSF, is shown in Table 1.
Inter-assay precision, which was determined 
using 21 replicates at 3 different ADA activity levels 
(low, medium and high) in PF and CSF samples, is 
shown in Table 2. Mean, standard deviation and CV 
were calculated.
Repeated determinations of ADA activity levels in 
those same samples were performed simultaneously 
using the modified Giusti method and the Diazyme 
commercial kit (Diazyme Laboratories, San Diego, 
CA, USA) with automation (ADVIA 1650 analyzer; 
Bayer Diagnostics, Tarrytown, NY, USA).
In order to perform the modified Giusti 
method,(16) the samples were centrifuged, and 
25 µL of the supernatant were transferred into test 
tubes, to which 500 µL of an adenosine solution 
were added. The mixture was heated at 37°C for 
60 min, and the reaction was interrupted by the 
addition of a phenol and nitroprusside solution and 
a hypochlorite solution. The resulting solution was 
then reheated at 37°C for 30 min. The quantity of 
ammonia released by the ADA activity was deter-
mined using spectrophotometry at 620 nm. In order 
to perform the automated Diazyme method, 11 µL 
of PF sample and 11 µL of commercial control 
material were used at two activity levels (high and 
low). For CSF samples, quantities of 22 µL were 
Figure 2 - Correlation (by linear regression) between the 
conventional (in-house) and the automated (Diazyme) 
methods for cerebrospinal fluid (CSF) samples. The 
correlation coefficient (r) was 0.95.
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Table 3 - Simple concordance test of the results obtained using the automated and the conventional methods in 
pleural fluid and cerebrospinal fluid samples.
Automated  
method: pleural fluid
Conventional  
method: ≥ 40 U/L
Conventional  
method: < 40 U/L
Total
≥ 30 U/L 14 2 16
< 30 U/L 1 77 78
Total 15 79 94*
Automated method: cerebrospinal fluid Conventional method: ≥ 9 U/L Conventional method: < 9  U/L Total
≥ 9 U/L 11 0 11
< 9 U/L 0 29 29
Total 11 29 40**
*96.8% concordance; and **100% concordance.
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racy, consequently weakening interlaboratory 
and intralaboratory correlations. In addition, the 
preparation of the specific, highly toxic reagents 
for use in the test requires trained, qualified 
professionals.
The organic fluid (PF and CSF) samples 
were selected at random from among those 
collected from patients with various diseases 
(among which were infectious, immunologic and 
neoplastic diseases) treated as inpatients at the 
HSP/ UNIFESP. The present study did not focus 
on clinical practice, since the authors were more 
interested in validating the laboratory method 
of ADA level determination, and, therefore, the 
samples selected had a wide range of ADA activity 
levels (high, medium and low).
The values found for the two types of organic 
fluid confirmed the strong correlation between the 
two methods (Figures 1 and 2).
The importance of the determination of ADA levels 
in organic fluids has been well established,(11,23,24) 
although the ideal cut-off level for this test, in the 
diagnosis of TB, remains controversial.
In the present study, we considered the cut-off 
level for the conventional method in PF samples 
to be 40 U/L, in accordance with recommenda-
tion of the SBPT,(8,12,19) although various studies 
have associated the clinical aspect with different 
ADA cut-off points.(21) For the automated method 
in PF samples, we suggested a cut-off value of 
30 U/L, after the mean percentage of the differ-
ences between the results obtained by the two 
methods had been calculated, and a value approx-
imately 30% lower was found for the automated 
method. With these cut-off levels, the concord-
ance between the methods was found to be 96.8% 
(simple concordance test), which is in accordance 
with the findings of other authors.(23)
In the literature, the cut-off value recom-
mended for the diagnosis of TB in CSF samples 
is 9 U/L. We considered this value for the two 
methods, since, using this value, concordance 
was found to be 100% (simple concordance test), 
although the mean percentage of the differences 
between the results obtained by the two methods 
was approximately 35%. It is likely that this value 
will be analyzed in detail and reevaluated in future 
studies, selecting samples of patients with a defi-
nite diagnosis.
For PF samples, the %CV values obtained at the 
3 different ADA activity levels (inter-assay precision) 
did not exceed 10%, whereas, for CSF samples, the 
mean values ranged from 13% to 20%.
Figures 1 and 2 show the correlation between 
the two methods for PF and CSF samples at different 
activity levels.
Table 3 presents the results of the simple 
concordance test. Considering the cut-off values of 
40 U/L (conventional method) and 30 U/L (auto-
mated method) for the detection of pleural TB in 
PF samples, the concordance was 96.8%. For the 
detection of meningeal TB in CSF samples, the 
cut-off value was 9 U/L (for both methods), and the 
concordance was 100%.
Discussion
It is of great relevance to evaluate the efficiency 
of alternative tests for the diagnosis of TB, espe-
cially that of the determination of ADA activity, 
which can be used in countries where TB preva-
lence is high, as announced by the Pan American 
Health Organization. In addition, the determination 
of ADA activity can, in many cases, favor the diag-
nostic confirmation, replacing biopsy, laparoscopy 
and other tests that definitively confirm the diag-
nosis but are more sophisticated, expensive and, in 
many health care facilities, unavailable.
Pulmonology societies, including the Sociedade 
Brasileira de Pneumologia e Tisiologia (SBPT, 
Brazilian Thoracic Association),(20) recommend the 
determination of ADA activity in organic fluids, 
especially in PF and CSF.(21) Therefore, the stand-
ardization of reliable automated methods is needed 
in order to define the diagnosis more rapidly and 
favor TB treatment.
However, the practicality and rapidity of the 
automated method proposed in the present study 
should be accompanied by a proper and useful 
validation so that the method can be used on a 
large scale.(22) There is considerable laboratory and 
clinical interest in standardizing an automated 
method that can replace the use of in-house 
methods, such as the modified Giusti (Berthelot) 
method, which, despite being considered defi-
nitely appropriate and having been available for 
at least two decades, is influenced by several 
interfering factors related to the execution of the 
technique, which decrease precision and accu-
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The results of the inter- and intra-assay precision 
tests were satisfactory, with %CV values appropriate 
for PF samples. However, for CSF samples, %CV 
values were higher because ADA activity levels are 
lower in CSF than in other cavitary fluids. In addi-
tion, CSF is much poorer in protein elements, as well 
as being known to present more unstable enzymatic 
and immunologic differences. In the present study, 
the %CV values for low ADA activity in PF samples 
were higher than those found for medium and high 
ADA activity in CSF samples.
Other aspects analyzed during the use of the 
automated method include reagent stability, which 
remained unaltered at 4°C for 6 months, the rapidity 
of obtaining results—approximately 10 min—and 
the (smaller) sample volume.
Based on the results obtained in the present 
study, the automated method, which was 
performed as described above, proved to be 
appropriate to replace the conventional (in-house) 
method without affecting the interpretation of 
the final result.
After the automated method is implemented 
in laboratory practice, it will be possible to 
perform clinical studies analyzing its sensitivity 
and specificity(22,25) for the diagnosis of TB and 
of other diseases that stimulate increased ADA 
activity, as well as to have standardized methods, 
which will allow better comparison of interlabora-
tory results.
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